Holly Roberts, NP
Nurse Practitioner · Opelika, ALNPI 1861583957
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $76 and has fallen 74.8% since, to $19 in 2024. That places this record below the midpoint for nurse practitioner clinicians in AL, where the typical reported total is $172.
Across 11 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$39
- Otsuka America Pharmaceutical, Inc.$36
- Acadia Pharmaceuticals Inc$21
- UCB, Inc.$19
- AstraZeneca$19
- Neurocrine Biosciences, Inc.$19
- plus $46 from 3 others
What the payments were for
- Food & beverage$199100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$199 in reported general payments places this provider in the 50th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $1,415 |
| Quetiapine Fumarate | 49 | $1,013 |
| Memantine Hcl | 27 | $929 |
| Pantoprazole Sodium | 24 | $516 |
| Tamsulosin Hcl | 19 | $484 |
| Simvastatin | 23 | $445 |
| Donepezil Hcl | 26 | $439 |
| Buspirone Hcl | 14 | $395 |
| Atorvastatin Calcium | 15 | $317 |
| Escitalopram Oxalate | 15 | $297 |
| Fluoxetine Hcl | 19 | $290 |
| Amlodipine Besylate | 30 | $288 |
| Risperidone | 23 | $280 |
| Metoprolol Tartrate | 13 | $270 |
| Losartan Potassium | 13 | $270 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Opelika
- Donald UptonOpelika$14K
- Carla HudsonOpelika$9K
- Brooke CauslandOpelika$8K
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$29K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.